Enhanced airway reactivity and inflammation in A2A adenosine receptor-deficient allergic mice

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 292, Issue 6, 2007, Pages

  Nadeem, Ahmed ^a   Fan, Ming ^b   Ansari, Habib R ^a   Ledent, Catherine ^c   Mustafa, S Jamal ^a,d  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

NF B signaling

Indexed keywords

ADENOSINE A2A RECEPTOR; CYCLIC AMP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHACHOLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BODY PLETHYSMOGRAPHY; CONTROLLED STUDY; DOWN REGULATION; KNOCKOUT MOUSE; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; WILD TYPE;

EID: 34447564893     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00416.2006     Document Type: Article

References (46)

1. 2A receptors promote adenosine-stimulated wound healing in bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 290: L849-L855, 2006.
2. Andreadis AA, Hazen SL, Comhair SA, Erzurum SC. Oxidative and nitrosative events in asthma. Free Radic Biol Med 35: 213-225, 2003.
3. Barnes PJ, Fan Chung K, Page CP. Inflammatory mediators of asthma: an update. Pharmacol Rev 50: 515-596, 1998.
4. 2A receptor activation in murine models of respiratory disorders. Am J Physiol Lung Cell Mol Physiol 290: L1036-L1043, 2006.
5. 2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells. J Leukoc Biol 72: 1027-1036, 2002.
6. Bureau F, Bonizzi G, Kirschvink N, Delhalle S, Desmecht D, Merville MP, Bours V, Lekeux P. Correlation between nuclear factor-κB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma. Am J Respir Crit Care Med 161: 1314-1321, 2000.
7. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 344: 350-362, 2001.
8. Driver AG, Kukoly CA, Ali S, Mustafa SJ. Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 148: 91-97, 1993.
9. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391: 393-397, 1998.
10. Escoubet-Lozach L, Glass CK, Wasserman SI. The role of transcription factors in allergic inflammation. J Allergy Clin Immunol 110: 553-564, 2002.
11. Fan M, Mustafa SJ. Adenosine-mediated bronchoconstriction and lung inflammation in an allergic mouse model. Pul Pharmacol Ther 15: 147-155, 2002.
12. Fan M, Qin W, Mustafa SJ. Characterization of adenosine receptor(s) involved in adenosine-induced bronchoconstriction in an allergic mouse model. Am J Physiol Lung Cell Mol Physiol 284: L1012-L1019, 2003.
13. 2A receptor agonist, on allergic airways inflammation in the rat. Eur J Pharmacol 438: 183-188, 2002.
14. Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, Linden J. International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53: 352-527, 2001.
15. Ghiselli A, Serafini M, Natella F, Scaccini N. Total antioxidant capacity to assess redox status: critical view and experimental data. Free Radic Biol Med 29: 1106-1114, 2000.
16. Grisham MB, Johnson GG, Lancaster JR. Quantitation of nitrate and nitrite in extracellular fluids. Methods Enzymol 268: 237-246, 1996.
17. 2B receptor-mediated vasorelaxation of mouse aorta. Am J Physiol Heart Circ Physiol 292: H719-H725, 2007.
18. Hart LA, Krishnan VL, Adcock IM, Barnes PJ, Chung KF. Activation and localization of transcription factor, nuclear factor-κB, in asthma. Am J Respir Crit Care Med 158: 1585-1592, 1998.
19. Heffner JE, Repine JE. Pulmonary strategies of antioxidant defense. Am Rev Respir Dis 140: 531-554, 1989.
20. Jentzsch AM, Bachmann H, Furst P, Biesalski HK. Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 20: 251-256, 1996.
21. Justice JP, Shibata Y, Sur S, Mustafa J, Fan M, Van Scott MR. IL-10 gene knockout attenuates allergen-induced airway hyperresponsiveness in C57BL/6 mice. Am J Physiol Lung Cell Mol Physiol 280: L363-L368, 2001.
22. Katsumata MJ, Miura M, Ichinose M, Kimura K, Takahasi T, Inoue H, Tikishima T. Oxygen radicals produce airway constriction and hyperresponsiveness in anaesthetized cats. Am Rev Respir Dis 141: 1158-1161, 1990.
23. 2A-adenosine receptor blunts constitutive activity: differential effect on cAMP accumulation and MAP kinase stimulation. Naunyn Schmiedebergs Arch Pharmacol 366: 287-298, 2002.
24. 2A agonists in development for the treatment of inflammation. Expert Opin Investig Drugs 14: 797-806, 2005.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2[-Delta Delta C(T)] method. Methods 25: 402-408, 2001.
26. 2A adenosine receptor in vivo. J Immunol 173: 21-24, 2004.
27. 3 adenosine receptors in lymphoid organs. Biochem Pharmacol 65: 2081-2090, 2003.
28. 2A receptors in human and porcine cardiovascular tissues. J Pharmacol Exp Ther 286: 1051-1057, 1998.
29. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 84: 407-412, 1993.
30. Minguet S, Huber M, Rosenkranz L, Schamel WW, Reth M, Brummer T. Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors. Eur J Immunol 35: 31-41, 2005.
31. Nadeem A, Chhabra SK, Masood A, Raj HG. Increased oxidative stress and altered levels of antioxidants in asthma. J Allergy Clin Immunol 111: 72-78, 2003.
32. Nadeem A, Chhabra SK, Raj HG. Increased oxidative stress in acute exacerbations of asthma. J Asthma 42: 45-50, 2005.
33. Nadeem A, Obiefuna PC, Wilson CN, Mustafa SJ. Adenosine A(1) receptor antagonist versus montelukast on airway reactivity and inflammation. Eur J Pharmacol 551: 116-124, 2006.
34. Nadeem A, Mustafa SJ. Adenosine receptor antagonists and asthma. Drug Disc Today: Therapeutic Strategies 3: 269-275, 2006.
35. Obiefuna PC, Batra VK, Nadeem A, Borron P, Wilson CN, Mustafa SJ. A novel A1 adenosine receptor antagonist (L-97-1) reduces allergic responses to house dust mite in an allergic rabbit model of asthma. J Pharmacol Exp Ther 315: 329-336, 2005.
36. Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414: 916-920, 2001.
37. 2A adenosine receptor: delineation of multiple processes. Mol Pharmacol 45: 1082-1094, 1994.
38. Parry GC, Mackman N. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-κB-mediated transcription. J Immunol 159: 5450-5456, 1997.
39. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydrils. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 266: 4244-4250, 1991.
40. Rubbo H, Radi R, Trujillo M, Telleri R, Kalyanraman B, Barnes S, Kirk M, Freeman BA. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. J Biol Chem 269: 26066-26075, 1994.
41. Sadeghi-Hashjin G, Folkerts G, Henricks PA, Verheyen AKCP, Linde HG, Ark I, Coene A, Nijkamp FP. Peroxynitrite induces airway hyperresponsiveness in guinea pigs in vitro and in vivo. Am J Respir Crit Care Med 153: 1697-1701, 1996.
42. Saleh D, Ernst P, Lim S, Barnes PJ, Giaid A. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J 12: 929-937, 1998.
43. 2A adenosine receptor gene transfer. Mol Pharmacol 66: 1147-1159, 2004.
44. 2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases. Microbes Infect 5: 515-526, 2003.
45. (2A) subtype adenosine receptor in the anti-inflammatory interactions of CGS 21680, cyclopentyladenosine, and IB-MECA with human neutrophils. Biochem Pharmacol 60: 993-999, 2000.
46. Wu W, Chen Y, Hazen SL. Eosinophil peroxidase nitrates protein tyrosyl residues: implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J Biol Chem 274: 25933-25944, 1999.